Rohit Bhatheja MD MBA, FACC, FSCAI (He/Him)
Interventional Cardiology, Peripheral Endovascular Interventional Cardiology, Vascular Medicine
Medical Director, Advent Health HLV Research
Join to View Full Profile
7485 Sandlake Commons BlvdOrlando, FL 32819
Phone+1 407-574-5155
Fax+1 877-673-3360
Dr. Bhatheja is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Rohit Bhatheja, MD is a specialized Cardiologist based in Orlando, Florida, with subspecialties in Interventional Cardiology, and Peripheral Endovascular Interventional Cardiology. He gained his expertise through fellowships in Cardiovascular Disease and Interventional Cardiology at the University of Kentucky College of Medicine, and a residency in Internal Medicine at Cleveland Clinic Foundation. His experience includes cardiac catheterization, left heart catheterization, percutaneous coronary intervention, and cardiac critical care. Dr. Bhatheja has authored numerous acclaimed publications and participated in several clinical trials. He has received honors including Meaningful Use Stage 1 Certification from the Centers for Medicare & Medicaid Services and a fellowship from the American College of Cardiology.
Education & Training
Northwestern UniversityMBA, Kellogg's School of Management, 2020 - 2021
University of Kentucky College of MedicineFellowship, Interventional Cardiology, 2008 - 2010- University of Kentucky College of MedicineFellowship, Cardiovascular Disease, 2005 - 2008
Cleveland Clinic FoundationResidency, Internal Medicine, 2003 - 2005
Maulana Azad Medical CollegeClass of 1999
Certifications & Licensure
FL State Medical License 2010 - 2026
KY State Medical License 2006 - 2012
PA State Medical License 2011 - 2011
OH State Medical License 2002 - 2005
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification GEMMS ONE, GEMMS, 2012-2017
- CMS Meaningful Use Stage 1 Certification GEMMS ONE, GEMMS, 2012-2017
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy Start of enrollment: 2012 Jun 07
- Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes Start of enrollment: 2013 May 01
- Coronary Orbital Atherectomy System Study Start of enrollment: 2014 Jun 01
Publications & Presentations
PubMed
- 17 citationsPCSK9 Inhibitors: The Evolving Future.Bijay Mukesh Jeswani, Shubhangi Sharma, Sawai Singh Rathore, Abubakar Nazir, Rohit Bhatheja
Health Science Reports. 2024-11-01 - Adenosine-Induced Atrial Fibrillation During Coronary Angiography and Fractional Flow Reserve Procedures.Rohit Bhatheja, Shammas Bajwa, Kapil Kapoor
Cureus. 2023-01-01 - 48 citationsPharmacomechanical Catheter-Directed Thrombolysis With the Bashir Endovascular Catheter for Acute Pulmonary Embolism: The RESCUE Study.Riyaz Bashir, Malcolm Foster, Ayman Iskander, Amir Darki, Wissam Jaber
JACC. Cardiovascular Interventions. 2022-12-12
Press Mentions
AdventHealth Doctor Says COVID-19 Hospitalizations on DeclineMay 20th, 2021
Professional Memberships
- Fellow
External Links
- Practice Websitehttps://hvmicardiology.com/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
